Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). IDECSI MyDataManagement is a commercial data access governance tool by IDECSI. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Mid-market and enterprise teams drowning in Microsoft 365 permission sprawl should pick IDECSI MyDataManagement because it actually surfaces who has access to what across Teams, SharePoint, and OneDrive without requiring weeks of manual auditing. The platform covers ID.AM asset management and PR.DS data security with automated permission reviews that hand remediation back to data owners instead of dumping everything on admins. Skip this if you need equal coverage for on-premises file servers and cloud together; the file server module exists but feels like an afterthought compared to the M365 focus.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise teams drowning in Microsoft 365 permission sprawl should pick IDECSI MyDataManagement because it actually surfaces who has access to what across Teams, SharePoint, and OneDrive without requiring weeks of manual auditing. The platform covers ID.AM asset management and PR.DS data security with automated permission reviews that hand remediation back to data owners instead of dumping everything on admins. Skip this if you need equal coverage for on-premises file servers and cloud together; the file server module exists but feels like an afterthought compared to the M365 focus.
Tool that immunizes Windows systems against critical vulnerabilities
Data governance & security platform for Microsoft 365 & file servers
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs IDECSI MyDataManagement for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
IDECSI MyDataManagement: Data governance & security platform for Microsoft 365 & file servers. built by IDECSI. Core capabilities include Audit and visibility for Microsoft 365 tenant resources and permissions, Automated permission reviews with data owners, Detection of dangerous operations and misconfigurations..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. IDECSI MyDataManagement differentiates with Audit and visibility for Microsoft 365 tenant resources and permissions, Automated permission reviews with data owners, Detection of dangerous operations and misconfigurations.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). IDECSI MyDataManagement is developed by IDECSI. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
360 High-Risk Vulnerability Immunization Tool V2.0 and IDECSI MyDataManagement serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox